查詢結果分析
相關文獻
- Percutaneous Ultrasound-guided Radiofrequency Ablation of Intrahepatic Cholangiocarcinoma
- 二氧化碳顯影電腦斷層與二氧化碳顯影超音波於肝臟腫瘤之比較
- Mesenchymal Hamartoma of the Liver: A Case Report
- Echo-Enhancing Sonography of Hepatic Tumors
- Experience of Using Microcatheter in Transcatheter Arterial Chemoembolization Therapy (TACE) for Hepatocellular Carcinoma
- 冷凍手術在肝臟惡性腫瘤的應用
- 三處多發性腫瘤--下咽癌、皮膚癌與肝臟腫瘤
- A Preliminary Report on the Optimal Method for Liver Cryosurgery--Microscopic Observations of Frozen Liver
- Ferrite-Enhanced MR Imaging of Hepatic Metastases: Animal Investigation
- 針刺麻醉應用於自體肝臟器官移植
頁籤選單縮合
題 名 | Percutaneous Ultrasound-guided Radiofrequency Ablation of Intrahepatic Cholangiocarcinoma=超音波導引下經皮熱射頻滅除術治療肝內膽管癌 |
---|---|
作 者 | 邱怡友; 黃振義; 周宜宏; 王信凱; 姜仁惠; 張政彥; | 書刊名 | The Kaohsiung Journal of Medical Sciences |
卷 期 | 21:7 民94.07 |
頁 次 | 頁304-309 |
分類號 | 416.247 |
關鍵詞 | 肝內膽管癌; 肝臟; 腫瘤; 熱射頻滅除術; Cholangiocarcinoma; Liver; Neoplasm; Radiofrequency ablation; |
語 文 | 英文(English) |
中文摘要 | 本研究是評估超音波導引下經皮熱射頻滅除術治療肝內膽管癌的臨床應用、治療效果,以及併發症。從 2002 年 1 月到 2004 年 10 月,共有 10 位病理診斷為肝內膽管癌的病人,接受了超音波導引下經皮熱射頻滅除術治療腫瘤。這些病人 (6 位男性與 4 位女性) 的平均年齡是 66.2 歲 (年齡範圍為 38 歲到 86 歲)。腫瘤的大小平均是 3.4 公分 (範圍 1.9 到 6.8 公分)。治療完後一個月以動態電腦攝影評估其效果,然後每隔 3 個月追蹤一次。有 6 個病人是使用內冷卻式的 Radionics 探針,另外 4 個病人是使用可擴張性的 RITA 探針。電腦斷層掃描檢查時注射顯影劑後腫瘤沒有顯影,則表示腫瘤已經壞死。這 10 位病人 (10 個腫瘤) 共接受了 12 次的治療,8 位病人接受 1 次治療,2 位病人接受 2 次治療。治療後動態電腦攝影顯示 8 位病人的腫瘤完全壞死。以腫瘤大小來評估其效果,小於 3 公分的腫瘤有5 位,腫瘤完全壞死率是 100%,3 到 5 公分有 3 位,腫瘤完全壞死率 67%,大於 5 公分的有 2 位,腫瘤完全壞死率 50%。1 位病人術後發生膽汁聚積的情形,經過引流,6 個月後已完全消失。總之,經皮熱射頻滅除術可以有效的治療肝內膽管癌,尤其是小於 3 公分的腫瘤,對於 3 到 5 公分腫瘤的療效也很不錯,治療後併發症的比例也很低。 |
英文摘要 | This study evaluated the clinical applications, treatment effects, and complications of percutaneous ultrasound (US)-guided radiofrequency ablation (RFA) of intrahepatic cholangiocarcinoma. Ten patients (6 men and 4 women) with histologically proven cholangiocarcinoma underwent US-guided percutaneous RFA. Tumor diameters ranged from 1.9 to 6.8 cm. There were 12 sessions of RFA for 10 solitary cholangiocarcinomas. Eight patients were treated at a single session and two patients had two treatment sessions. The efficacy of RFA was evaluated using contrast-enhanced dynamic computed tomography 1 month after treatment and then every 3 months. Complete necrosis was defined as lack of contrast enhancement of the treated region. There was complete necrosis in eight tumors. In two patients with large tumors (4.7 and 6.8 cm in diameter), enhancement of residual tissue was observed after RFA treatment, indicating residual tumor. Complete necrosis was seen in all five tumors (100%) with diameters of 3.0 cm or less, two of three tumors (67%) with diameters of 3.1-5.0 cm, and one of two tumors (50%) with diameters of more than 5.0 cm. A large biloma was found in one patient after treatment. No serious complications occurred in the other nine patients. In conclusion, percutaneous RFA is effective and successful in the treatment of intrahepatic cholangiocarcinoma of 3 cm or less and satisfactory for tumors of 3-5 cm. The rate of serious complications after RFA is low. Further follow-up is necessary to determine long-term efficacy. |
本系統中英文摘要資訊取自各篇刊載內容。